Alignment Healthcare ALHC Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $1.24B+33.3% | $1.01B+44.4% | $993.7M+43.5% | $1.02B+49.0% | $926.93M+47.5% | ||
| $121.14M+16.7% | $125.76M+23.1% | $110.02M+21.1% | $103.8M+18.1% | $103.83M+14.7% | ||
| $1.22B+30.8% | $1.02B+41.4% | $986.01M+38.5% | $992.54M+41.9% | $932.33M+39.2% | ||
| $15.5M+387% | —— | $7.68M+139% | $22.75M+224% | -$5.39M+86.9% | ||
| 1.3%+1.8pp | —— | 0.8%+3.6pp | 2.2%+4.9pp | -0.6%+6.0pp | ||
| $4.06M+2.8% | $3.95M-28.1% | $3.95M-43.1% | $3.95M-30.6% | $3.95M-27.2% | ||
| -$4.06M-3.1% | -$3.95M+53.6% | -$3.95M+42.9% | -$3.87M+30.9% | -$3.94M+28.0% | ||
| $11.44M+223% | -$14.23M+54.2% | $3.73M+114% | $18.88M+179% | -$9.33M+80.0% | ||
| $25K+19.0% | —— | $2K+125% | $3.22M+14,555% | $21K— | ||
| $11.42M+225% | -$11.01M+64.6% | $3.73M+114% | $15.67M+165% | -$9.11M+80.4% | ||
| 0.9%+1.9pp | -1.1%+3.3pp | 0.4%+4.2pp | 1.5%+5.1pp | -1%+6.4pp | ||
| $0.05+200% | -$0.05+68.8% | $0.02+114% | $0.07+154% | -$0.05+80.0% | ||
| $23.34M+961% | -$2.45M+84.5% | $15.66M+232% | $29.75M+350% | $2.2M+106% | ||
| 1.9%+1.7pp | -0.2%+2.0pp | 1.6%+3.3pp | 2.9%+4.7pp | 0.2%+5.8pp | ||
| $15.5M+387% | -$10.28M+54.4% | $7.68M+139% | $22.75M+224% | -$5.39M+86.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Alignment Healthcare's revenue?
- Alignment Healthcare (ALHC) generated $4.3B in revenue over the trailing twelve months, up 41.8% year over year.
- Is Alignment Healthcare profitable?
- Alignment Healthcare reported $19.8M in net income over the trailing twelve months, a 0.5% net margin.
- What is Alignment Healthcare's earnings per share?
- Alignment Healthcare's diluted EPS over the trailing twelve months is $0.09.
- Where does Alignment Healthcare's income statement data come from?
- Every line is extracted from Alignment Healthcare's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
